keyword
https://read.qxmd.com/read/38723929/an-exploratory-analysis-of-routine-ferritin-measurement-upon-admission-and-the-prognostic-implications-of-low-grade-ferritinemia-during-inflammation
#1
JOURNAL ARTICLE
Rafael Y Brzezinski, Asaf Wasserman, Noa Sasson, Moshe Stark, Ilana Goldiner, Ori Rogowski, Shlomo Berliner, Ori Argov
BACKGROUND: Serum ferritin is usually measured in the presence of anemia or in suspected iron overload syndromes. Ferritin is also an acute-phase protein that is elevated during systemic inflammation. However, the prognostic value of routinely measuring ferritin upon admission to a medical facility is not clear. Therefore, we examined the association between ferritin concentrations measured at the time of hospital admission with 30-day and long-term mortality. METHODS: We obtained routine ferritin measurements taken within 24 hours of admission in 2,859 patients hospitalized in an internal medicine department...
May 7, 2024: American Journal of Medicine
https://read.qxmd.com/read/38638373/a-revised-classification-of-primary-iron-overload-syndromes
#2
JOURNAL ARTICLE
Yasuaki Tatsumi, Motoyoshi Yano, Shinya Wakusawa, Hiroaki Miyajima, Tetsuya Ishikawa, Shinsaku Imashuku, Atsuko Takano, Wataru Nihei, Ayako Kato, Koichi Kato, Hisao Hayashi, Kentaro Yoshioka, Kazuhiko Hayashi
BACKGROUND AND AIMS: The clinical introduction of hepcidin25 (Hep25) has led to a more detailed understanding of its relationship with ferroportin (FP) and divalent metal transporter1 in primary iron overload syndromes (PIOSs). In 2012, we proposed a classification of PIOSs based on the Hep25/FP system, which consists of prehepatic aceruloplasminemia, hepatic hemochromatosis (HC), and posthepatic FP disease (FP-D). However, in consideration of accumulated evidence on PIOSs, we aimed to renew the classification...
April 28, 2024: Journal of Clinical and Translational Hepatology
https://read.qxmd.com/read/38637332/diagnosing-aceruloplasminemia-navigating-through-red-herrings
#3
JOURNAL ARTICLE
Zeni Kharel, Himal Kharel, Pradyumna D Phatak
A 58-year-old female was found to have hyperferritinemia (Serum ferritin:1683 ng/mL) during work-up for mild normocytic anemia. Transferrin saturation(TSAT) was low-normal. Magnetic resonance imaging (MRI) abdomen showed evidence of hepatic iron deposition. Liver biopsy showed 4 + hepatic iron deposition without any evidence of steatosis or fibrosis. Quantitative liver iron was elevated at 348.3 µmol/g dry liver weight [Reference range(RR): 3-33 µmol/g dry liver weight]. She was presumptively diagnosed with tissue iron overload, cause uncertain...
April 19, 2024: Annals of Hematology
https://read.qxmd.com/read/38557364/express-a-new-therapeutic-perspective-erastin-inhibits-tumor-progression-by-driving-ferroptosis-in-myelodysplastic-syndromes
#4
JOURNAL ARTICLE
Junlan Ma, Wei Zhang, Jiaojiao Li, Rui Zhang, Yan Zhai, Rong Fu
Ferroptosis is a recently identified and evolutionarily conserved form of programmed cell death. This process is initiated by an imbalance in iron metabolism, leading to an overload of ferrous ions. These ions promote lipid peroxidation in the cell membrane through the Fenton reaction. As the cell's antioxidant defenses become overwhelmed, a fatal build-up of reactive oxygen species (ROS) occurs, resulting in the rupture of the plasma membrane. Ferroptosis is implicated in conditions such as ischemia-reperfusion injuries and a range of cancers...
April 1, 2024: Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research
https://read.qxmd.com/read/38555469/luspatercept-in-low-risk-myelodysplastic-syndromes-a-paradigm-shift-in-treatment-strategies
#5
REVIEW
Matteo Molica, Marco Rossi
INTRODUCTION: In patients with myelodysplastic syndromes (MDS), anemia is prevalent affecting 80%-85% of low-risk (LR-MDS) patients, with 40% eventually requiring red blood cell (RBC) transfusions. Except forlenalidomide, exclusively approved for those with deletion of chromosome 5q,erythropoiesis-stimulating agents (ESAs) are the primary treatment choice for low-risk patients. Those unresponsive to ESAs face limited alternatives, eventually necessitating long-term RBC transfusions, leading to secondary iron overload and adversely affecting quality of life (QoL)...
March 30, 2024: Expert Opinion on Biological Therapy
https://read.qxmd.com/read/38543737/effects-of-hcv-clearance-with-direct-acting-antivirals-daas-on-liver-stiffness-liver-fibrosis-stage-and-metabolic-cellular-parameters
#6
JOURNAL ARTICLE
Joana Ferreira, Manuel Bicho, Fátima Serejo
INTRODUCTION: Chronic hepatitis C (CHC) is a clinical and pathological syndrome with various causes and is characterized by varying degrees of hepatocellular necrosis and inflammation. It is a significant cause of liver transplantation and liver-related death worldwide. The hepatic manifestations of CHC are typically characterized by slowly progressing liver fibrosis, which is a non-specific and often disproportionate response to tissue damage. A large majority of HCV patients have extrahepatic manifestations with varying degrees of severity...
February 27, 2024: Viruses
https://read.qxmd.com/read/38524657/severe-hepatic-sinusoidal-obstruction-syndrome-in-a-patient-with-wilms-tumor-and-hereditary-spherocytosis
#7
JOURNAL ARTICLE
Dildar Bahar Genc, Zeynep Yildiz Yildirmak, Ferhat Sari, Ismail Uzak
A 7-year-old girl with a history of splenectomy for hereditary spherocytosis (HS) was diagnosed with renal hematoma after a blunt abdominal trauma while receiving aspirin. Multiple erythrocyte transfusions and transarterial embolization were performed without success. Eventual nephrectomy revealed severely necrotic and perforated Stage III Wilms tumor (WT). Radiochemotherapy was administered, but by the eighth week, she developed severe hepatic sinusoidal obstruction syndrome (HSOS). Her ferritin level at the time was 3406 ng/ml...
April 2024: International cancer conference journal
https://read.qxmd.com/read/38457773/haemoglobin-bart-s-hydrops-fetalis-charting-the-past-and-envisioning-the-future
#8
JOURNAL ARTICLE
Ali Amid, Siyu Liu, Christian Babbs, Douglas R Higgs
Haemoglobin Bart's hydrops fetalis syndrome (BHFS) represents the most severe form of α-thalassaemia, arising from deletion of the duplicated α-globin genes from both alleles. The absence of α-globin leads to the formation of non-functional haemoglobin Bart's (γ4) or haemoglobin H (HbH: β4) resulting in severe anaemia, tissue hypoxia, and, in some cases, variable congenital or neurocognitive abnormalities. BHFS is the most common cause of hydrops fetalis in Southeast Asia; however, owing to global migration, the burden of this condition is increasing worldwide...
March 8, 2024: Blood
https://read.qxmd.com/read/38447712/c5b-9-promotes-ferritinophagy-leading-to-ferroptosis-in-renal-tubular-epithelial-cells-of-trichloroethylene-sensitized-mice
#9
JOURNAL ARTICLE
Zhibing Liu, Sifan Zhou, Feng Wang, Haibo Xie, Jiaxiang Zhang, Changhao Wu, Dexiang Xu, Qixing Zhu
Trichloroethylene (TCE) is a common environmental contaminant that can cause a severe allergic reaction called TCE hypersensitivity syndrome, which often implicates the patient's kidneys. Our previous study revealed that C5b-9-induced tubular ferroptosis is involved in TCE-caused kidney damage. However, the study did not explain how tubule-specific C5b-9 causes free iron overload, a key event in ferroptosis. Here, we aimed to explore the role of NCOA4-mediated ferritinophagy in C5b-9-induced iron overload and ferroptosis in TCE-sensitized mice...
March 4, 2024: Science of the Total Environment
https://read.qxmd.com/read/38408490/the-effect-of-ferroptosis-related-mitochondrial-dysfunction-in-the-development-of-temporal-lobe-epilepsy
#10
REVIEW
Yang Su, Ningrui Cao, Dingkun Zhang, Minjin Wang
Temporal lobe epilepsy (TLE) is the most common form of epileptic syndrome. It has been established that due to its complex pathogenesis, a considerable proportion of TLE patients often progress to drug-resistant epilepsy. Ferroptosis has emerged as an important neuronal death mechanism in TLE, which is primarily influenced by lipid accumulation and oxidative stress. In previous studies of ferroptosis, more attention has been focused on the impact of changes in the levels of proteins related to the redox equilibrium and signaling pathways on epileptic seizures...
February 24, 2024: Ageing Research Reviews
https://read.qxmd.com/read/38376738/role-of-epinephrine-in-attenuating-cytokine-storm-decreasing-ferritin-and-inhibiting-ferroptosis-in-sars-cov-2
#11
JOURNAL ARTICLE
Ashraf El-Molla, Fawzia Aboul Fetouh, Samir Bawazir, Yasser Ali, Yehya Alwahby, Muhammad Bahadeg, Yousef Gotah, Fatima Ahmed Badahdah, Abdullatif H Alsaeed, Abdullah Basseet
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for coronavirus disease 2019. It presents one of the most threatening pandemics in the history of humanity. The mortality and morbidity represent an unprecedented challenge to the modern medical era. SARS-CoV-2 results in acute respiratory distress syndrome, high concentrations of proinflammatory mediators, cytokine storm (CS) due to massive release of cytokines, hypercoagulation, and hemoglobin disintegration...
February 20, 2024: Egyptian Heart Journal: EHJ
https://read.qxmd.com/read/38355658/author-correction-zinc-nanoparticles-ameliorated-obesity-induced-cardiovascular-disease-role-of-metabolic-syndrome-and-iron-overload
#12
Samir A E Bashandy, Ahmed M A El-Seidy, Fatma A A Ibrahim, Sahar S Abdelrahman, Sherif A Abdelmottaleb Moussa, Marawan A ElBaset
No abstract text is available yet for this article.
February 14, 2024: Scientific Reports
https://read.qxmd.com/read/38354712/eicosanoids-and-oxylipin-signature-in-hh-patients-are-similar-to-dios-patients-but-are-impacted-by-dietary-iron-absorption
#13
JOURNAL ARTICLE
Hervé Lobbes, Céline Dalle, Bruno Pereira, Marc Ruivard, Andrzej Mazur, Cécile Gladine
INTRODUCTION: Oxylipins are mediators of oxidative stress. To characterize the underlying inflammatory processes and phenotype the effect of iron metabolism disorders, we investigated the oxylipin profile in hereditary hemochromatosis (HH) and dysmetabolic iron overload syndrome (DIOS) patients. METHODS: LC-MS/MS based method to quantify plasma oxylipins in 20 HH and 20 DIOS patients in fasting conditions and 3 hours after an iron-rich meal in HH patients. RESULTS: Principal component analysis showed no separation between HH and DIOS, suggesting that the clinical phenotype has no direct impact on oxylipin metabolism...
February 14, 2024: Annals of Nutrition & Metabolism
https://read.qxmd.com/read/38343073/cardiac-effects-of-deferasirox-in-transfusion-dependent-patients-with-myelodysplastic-syndromes-telesto-study
#14
JOURNAL ARTICLE
Matteo Sarocchi, Junmin Li, Xiao Li, Depei Wu, Efreen Montaño Figueroa, Maria Guadalupe Rodriguez, Ming Hou, Carlo Finelli, Hong-Xia Shi, Zhijian Xiao, Esther Natalie Oliva, Liana Gercheva Kyuchukova, Mark Drummond, Argiris Symeonidis, Eric J Velazquez, Giulia Rivoli, Miguel Izquierdo, Yogita Kolekar, Paolo Spallarossa, Emanuele Angelucci
Iron overload from repeated transfusions has a negative impact on cardiac function, and iron chelation therapy may help prevent cardiac dysfunction in transfusion-dependent patients with myelodysplastic syndromes (MDS). TELESTO (NCT00940602) was a prospective, placebo-controlled, randomised study to evaluate the iron chelator deferasirox in patients with low- or intermediate-1-risk MDS and iron overload. Echocardiographic parameters were collected at screening and during treatment. Patients receiving deferasirox experienced a significant decrease in the composite risk of hospitalisation for congestive heart failure (CHF) or worsening of cardiac function (HR = 0...
February 11, 2024: British Journal of Haematology
https://read.qxmd.com/read/38305197/potential-anticancer-effect-of-free-and-nanoformulated-deferasirox-for-breast-cancer-treatment-in-vitro-and-in-vivo-evaluation
#15
JOURNAL ARTICLE
Nadeen Diaa Abdel-Wahab, Mohamed Fawzi Kabil, Ibrahim M El-Sherbiny, Mohamed F Salama, Gehad El-Sayed, El-Said El-Sherbini
Background: Breast cancer (BC) stands as the second leading cause of mortality among women worldwide. Many chemotherapeutic treatments for BC come with significant adverse effects. Additionally, BC is recognized as one of the most resistant forms of malignancy to treatment. Consequently, there exists a critical need for innovative therapeutic agents that are both highly effective and exhibit reduced toxicity and side effects for patients. Deferasirox (DFX), an iron-chelating drug approved by the FDA for oral use, emerges as a promising contender in the fight against BC proliferation...
February 2, 2024: Drug Development and Industrial Pharmacy
https://read.qxmd.com/read/38272521/iron-overload-in-patients-with-crohn-s-disease-with-short-bowel-syndrome-who-received-long-term-parenteral-nutrition-with-trace-elements
#16
JOURNAL ARTICLE
Yosuke Shimodaira, Sho Fukuda, So Takahashi, Katsunori Iijima
Crohn's disease patients often need regular home parenteral nutrition (HPN) for intestinal failure due to multiple intestinal resections. Trace elements are necessary for long-term HPN but the requirement volume of iron is undetermined. We describe three patients with Crohn's disease with short bowel syndrome (SBS) who had iron overload as a result of long-term HPN including iron. Serum ferritin level was significantly decreased through depleting intravenous iron administration in all cases. One patient needed regular insulin injection and phlebotomy for diabetes mellitus due to hemochromatosis, and intravenous iron administration had a significant impact on the patient's health...
January 25, 2024: BMJ Case Reports
https://read.qxmd.com/read/38254820/the-role-of-hepcidin-in-myelodysplastic-syndromes-mds-a-systematic-review-of-observational-studies
#17
REVIEW
Artur Słomka, Anna Pokrzywa, Dominika Strzała, Maja Kubiaczyk, Oliwia Wesolowska, Kinga Denkiewicz, Jan Styczyński
Iron overload emerges as a serious complication in myelodysplastic syndromes (MDS), particularly associated with frequent transfusions during the course of the disease. The discovery and description of hepcidin's mechanisms of action have contributed to a deeper understanding of iron metabolism. The existing literature reports a potential role of hepcidin in MDS, yet these data are fragmented and presented in an unstructured, somewhat chaotic manner. Hence, to address the existing data, we performed a systematic review of observational studies examining hepcidin levels in MDS...
January 11, 2024: Cancers
https://read.qxmd.com/read/38250286/brief-report-of-complicated-yersinia-enterocolitica-infection-in-an-immunocompetent-host-review-of-the-literature-and-pathogenicity-mechanisms
#18
JOURNAL ARTICLE
Sunil Samnani, Helen Bibby, LeeAnne Luft
BACKGROUND: We report a case of a 47-year-old male presenting with Yersinia enterocolitica septicemia with no known risk factors for invasive infection, found to have multiloculated liver and splenic abscesses with an antecedent history of mild enterocolitis. CASE PRESENTATION: Our patient presented with septic shock in the setting of gastroenteritis with abdominal pain and fever. On work-up, he was found to have multiloculated hepatic and splenic abscesses secondary to Y...
September 2023: Journal of the Association of Medical Microbiology and Infectious Disease Canada, Journal officiel de l’Association pour la microbiologie médicale et l’infectiologie Canada
https://read.qxmd.com/read/38206762/managing-sickle-cell-disease-and-related-complications-in-pregnancy-results-of-an-international-delphi-panel
#19
JOURNAL ARTICLE
Deva Sharma, Ilknur Kozanoğlu, Kenneth I Ataga, Alexandra Benachi, Selim Büyükkurt, Sophie Lanzkron, Hakan Ozdogu, Shivan Pancham, Lydia H Pecker, Susan Robinson, Safak Yilmaz Baran, Jo Howard
Data to guide evidence-based management of pregnant people with sickle cell disease (SCD) is limited. This international Delphi panel aimed to identify consensus among multidisciplinary experts for SCD management during pregnancy. The two-round Delphi process used questionnaires exploring seven topics (antenatal care, hydroxyurea use, transfusion, prevention of complications, treatment of complications, delivery and follow-up, and bottlenecks and knowledge gaps) developed by a steering committee. Thirteen panelists (hematologists, physiologists, obstetricians, maternal fetal medicine and transfusion medicine physicians) from the US, the UK, Turkey and France completed the first survey; 12 panelists completed the second round...
January 4, 2024: Blood Advances
https://read.qxmd.com/read/38186421/clinical-and-laboratory-characteristics-of-individuals-aged-%C3%A2-17-years-with-homeostatic-iron-regulator-hfe-p-c282y-homozygosity-a-common-hemochromatosis-genotype
#20
JOURNAL ARTICLE
James C Barton, Jackson C Barton, Ronald T Acton
Background Characteristics of cohorts of individuals aged ≤17 years with homeostatic iron regulator ( HFE ) p.C282Y (rs1800562) homozygosity, a common hemochromatosis genotype, have not been reported. Methodology We retrospectively tabulated characteristics of white individuals aged ≤17 years with p.C282Y homozygosity. Individuals were not recruited for this study. We defined transferrin saturation (TS) >45%, serum ferritin (SF) >300 µg/L (M) and >200 µg/L (F) as elevated and liver iron grade 3 or 4, hepatic iron index >1...
December 2023: Curēus
keyword
keyword
166538
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.